Startup accelerator & VC Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | 2CFinance fintech, Financial Services | Other 24 Oct 2023 | | |
 | AI for Health healthtech, IT Services and IT Consulting | Other 23 Oct 2023 | | |
 | Almi Business Consulting and Services | Other 1 Sep 2020 | | |
 | Alpha Intelligence Capital fintech, IT Services, Venture Capital and Private Equity Principals | Other 16 Apr 2024 | | |
 | Amolyt Pharma biotech, deeptech, Biotechnology Research | Other 15 Mar 2024 | | |
 | Andrew Lloyd & Associates Public Relations and Communications Services | Other 7 Sep 2023 | | |
 | Angels Santé Venture Capital and Private Equity Principals | Other 28 Apr 2021 12 Jun 2023 | | |
 | Artefact martech, Business Consulting and Services | Other 22 Nov 2023 | | |
 | Asabys Partners Venture Capital and Private Equity Principals | Other 28 Feb 2023 | | |
 | BNP Paribas Développement Venture Capital and Private Equity Principals | Other 23 Oct 2023 | | |